CoChat
Sign Up
Cited by 356Ovarian function and disordersReproductive Biology and FertilitySexual Differentiation and Disorders

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome

Open access
Risal, Sanjiv, Pei, Yu, Lu, Haojiang, Manti, Maria, Fornes, Romina, Pui, Han-Pin, Zhao, Zhiyi, Massart, Julie, Ohlsson, Claes, Lindgren, Eva, Crisosto, Nicolas, Maliqueo, Manuel, Echiburú, Barbara, Ladrón de Guevara, Amanda, Sir-Petermann, Teresa, Larsson, Henrik, Rosenqvist, Mina A., Cesta, Carolyn E., Benrick, Anna, Deng, Qiaolin, Stener-Victorin, Elisabet·2019·Nature Medicine
DOI 10.1038/s41591-019-0666-1
Open this paper in CoChat — free account

Abstract

How obesity and elevated androgen levels in women with polycystic ovary syndrome (PCOS) affect their offspring is unclear. In a Swedish nationwide register-based cohort and a clinical case-control study from Chile, we found that daughters of mothers with PCOS were more likely to be diagnosed with PCOS. Furthermore, female mice (F 0) with PCOS-like traits induced by late-gestation injection of dihydrotestosterone, with and without obesity, produced female F 1-F 3 offspring with PCOS-like reproductive and metabolic phenotypes. Sequencing of single metaphase II oocytes from F 1-F 3 offspring revealed common and unique altered gene expression across all generations. Notably, four genes were also differentially expressed in serum samples from daughters in the case-control study and unrelated women with PCOS. Our findings provide evidence of transgenerational effects in female offspring of mothers with PCOS and identify possible candidate genes for the prediction of a PCOS phenotype in future generations.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41591-019-0666-1

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. Sharma, N. et al. Tpbpa–Cre-mediated deletion of TFAP2C leads to deregulation of Cdkn1a, Akt1 and the ERK pathway, causing placental growth arrest. Development 143, 787–798 (2016).

Cited by

Sorted by citations

Items 301–354 of 354

Related

See all

Metadata

Authors
Risal, S., Pei, Y., Lu, H., Manti, M., Fornes, R., Pui, H.-P., Zhao, Z., Massart, J., Ohlsson, C., Lindgren, E., Crisosto, N., Maliqueo, M., Echiburú, B., Ladrón de Guevara, A., Sir-Petermann, T., Larsson, H., Rosenqvist, M. A., Cesta, C. E., Benrick, A., Deng, Q., & Stener-Victorin, E.
Affiliations
  • Karolinska Institutet (SE)
  • Karolinska University Hospital (SE)
  • University of Gothenburg (SE)
  • University of Chile (CL)
  • Örebro University (SE)
  • University of Skövde (SE)
Corresponding author
Deng, Qiaolin
ORCID
Venue
Nature Medicine
Publisher
Springer Science and Business Media LLC
Published
2019-12
Volume
25
Issue
12
Pages
1894-1904
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
DOI
10.1038/s41591-019-0666-1
OpenAlex
W2989769687
Cited by
356
References
73
Citations by year
2026: 39 · 2025: 61 · 2024: 60 · 2023: 58 · 2022: 60 · 2021: 46 · 2020: 29 · 2019: 2
FWCI
32.74
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, public-domain)
  • DRYAD (public-domain)
Funders
  • Åke Wiberg Stiftelse
  • Vetenskapsrådet (2014-02775, 2014-2870 QD, 2018-02435 ESV, 2018-02119 MR)
  • Novo Nordisk Fonden (NNF14OC0010513, NNF18OC0033898, NNF13OC0005785, NNF18OC0033992, NNF19OC0056647)
  • Novo Nordisk Foundation Center for Basic Metabolic Research (NNF19OC0056647, NNF16OC0020744, NNF17OC0026724, NNF18OC0033992)
  • Fondo Nacional de Desarrollo Científico y Tecnológico (1181798 to MM)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords
polycystic ovary syndrome, transgenerational effects, prenatal androgen exposure, dihydrotestosterone, maternal obesity, female offspring, oocyte gene expression, candidate genes, reproductive phenotypes, metabolic phenotypes, epigenetics
MeSH terms
Pregnancy in Obesity, Androgens, Animals, Female, Humans, Nuclear Family, Oocytes, Phenotype, Polycystic Ovary Syndrome, Pregnancy, Prenatal Exposure Delayed Effects, Cohort Studies, Gene Expression Regulation, Developmental, Mice, Single-Cell Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review